Phase I immunotoxin trial in patients with B-cell lymphoma
- Author
- VITETTA, E. S1 ; STONE, M; GHETIE, V; UHR, J. W; THORPE, P. E; AMLOT, P; FAY, J; MAY, R; TILL, M; NEWMAN, J; CLARK, P; COLLINS, R; CUNNINGHAM, D
[1] Univ. Texas southewestern medical cent., dep. microbiology, Dallas TX 75235, United States - Source
Cancer research (Baltimore). 1991, Vol 51, Num 15, pp 4052-4058 ; ref : 38 ref
- CODEN
- CNREA8
- ISSN
- 0008-5472
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticorps monoclonal Chimiothérapie Efficacité traitement Essai clinique phase I Essai thérapeutique contrôlé Fragment peptidique F(ab')2 Homme Hémopathie maligne Immunochimiothérapie Immunotoxine Lymphocyte B Lymphome non hodgkinien Lymphoprolifératif syndrome Stade clinique Toxicité Toxine Traitement Voie intraveineuse Antigène CD22 Ricine A
- Keyword (en)
- Monoclonal antibody Chemotherapy Treatment efficiency Phase I trial Controlled therapeutic trial F(ab')2-Fragment Human Malignant hemopathy Immunochemotherapy Immunotoxin B-Lymphocyte Non Hodgkin lymphoma Lymphoproliferative syndrome Clinical stage Toxicity Toxin Treatment Intravenous administration
- Keyword (es)
- Anticuerpo monoclonal Quimioterapia Eficacia tratamiento Ensayo clínico fase I Ensayo terapéutico controlado Fragmento peptídico F(ab')2 Hombre Hemopatía maligna Inmunoquimioterapia Inmunotoxina Linfocito B Linfoma no Hodgkin Linfoproliferativo síndrome Estadio clínico Toxicidad Toxina Tratamiento Vía intravenosa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 5043170
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"4052\";s:8:\"\u0000*\u0000epage\";s:4:\"4058\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VITETTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"STONE, M\";i:1;s:9:\"GHETIE, V\";i:2;s:9:\"UHR, J. W\";i:3;s:12:\"THORPE, P. E\";i:4;s:8:\"AMLOT, P\";i:5;s:6:\"FAY, J\";i:6;s:6:\"MAY, R\";i:7;s:7:\"TILL, M\";i:8;s:9:\"NEWMAN, J\";i:9;s:8:\"CLARK, P\";i:10;s:10:\"COLLINS, R\";i:11;s:13:\"CUNNINGHAM, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"4052\";s:8:\"\u0000*\u0000epage\";s:4:\"4058\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VITETTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"STONE, M\";i:1;s:9:\"GHETIE, V\";i:2;s:9:\"UHR, J. W\";i:3;s:12:\"THORPE, P. E\";i:4;s:8:\"AMLOT, P\";i:5;s:6:\"FAY, J\";i:6;s:6:\"MAY, R\";i:7;s:7:\"TILL, M\";i:8;s:9:\"NEWMAN, J\";i:9;s:8:\"CLARK, P\";i:10;s:10:\"COLLINS, R\";i:11;s:13:\"CUNNINGHAM, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"4052\";s:8:\"\u0000*\u0000epage\";s:4:\"4058\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VITETTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"STONE, M\";i:1;s:9:\"GHETIE, V\";i:2;s:9:\"UHR, J. W\";i:3;s:12:\"THORPE, P. E\";i:4;s:8:\"AMLOT, P\";i:5;s:6:\"FAY, J\";i:6;s:6:\"MAY, R\";i:7;s:7:\"TILL, M\";i:8;s:9:\"NEWMAN, J\";i:9;s:8:\"CLARK, P\";i:10;s:10:\"COLLINS, R\";i:11;s:13:\"CUNNINGHAM, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"4052\";s:8:\"\u0000*\u0000epage\";s:4:\"4058\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VITETTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"STONE, M\";i:1;s:9:\"GHETIE, V\";i:2;s:9:\"UHR, J. W\";i:3;s:12:\"THORPE, P. E\";i:4;s:8:\"AMLOT, P\";i:5;s:6:\"FAY, J\";i:6;s:6:\"MAY, R\";i:7;s:7:\"TILL, M\";i:8;s:9:\"NEWMAN, J\";i:9;s:8:\"CLARK, P\";i:10;s:10:\"COLLINS, R\";i:11;s:13:\"CUNNINGHAM, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Cancer research (Baltimore)\";s:9:\"\u0000*\u0000stitle\";s:23:\"Cancer res. (Baltimore)\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"51\";s:8:\"\u0000*\u0000issue\";s:2:\"15\";s:8:\"\u0000*\u0000spage\";s:4:\"4052\";s:8:\"\u0000*\u0000epage\";s:4:\"4058\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VITETTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"E. S\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:8:\"STONE, M\";i:1;s:9:\"GHETIE, V\";i:2;s:9:\"UHR, J. W\";i:3;s:12:\"THORPE, P. E\";i:4;s:8:\"AMLOT, P\";i:5;s:6:\"FAY, J\";i:6;s:6:\"MAY, R\";i:7;s:7:\"TILL, M\";i:8;s:9:\"NEWMAN, J\";i:9;s:8:\"CLARK, P\";i:10;s:10:\"COLLINS, R\";i:11;s:13:\"CUNNINGHAM, D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:58:\"Phase I immunotoxin trial in patients with B-cell lymphoma\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
